Siliq (brodalumab) - Bausch Health, Leo Pharma, Kyowa Hakko Kirin
Brodalumab: Regulatory decision in Asia for psoriasis in 2020 (Kyowa Hakko Kirin Pharma) - Feb 6, 2020 - FY 2019 Results 
Non-US regulatory
https://ir.kyowakirin.com/en/library/earnings/earnings0/main/03/teaserItems1/00/linkList/01/link/presentation_2019_q4_en2.pdf
 
Feb 6, 2020
 
 
15dd47a8-5877-4807-96e1-ad8f36d6040e.jpg